Clinical Trials Arena on MSN
OS endpoint focus will realign industry to “ultimate goal”
While OS is still the king of the oncology endpoints, experts note it may soon be phased out due to the introduction of better, more advanced cancer therapies.
Shaka Smart’s Marquette Golden Eagles are dogged defenders - and the numbers are reflecting it. They rank 28 th in the nation in steals. They are No. 1 in the Big East and No. 5 in the NCAA in ...
The proposal comes after Trump announced plans for companies to pay a new $100,000 fee on H-1B visas, which are used by companies to hire foreign workers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback